Shares of Cyclo Therapeutics, Inc. (OTCMKTS:CTDH) hit a new 52-week high during mid-day trading on Monday . The company traded as high as $7.15 and last traded at $6.47, with a volume of 166116 shares. The stock had previously closed at $7.10.
The stock’s 50-day moving average is $8.11 and its 200-day moving average is $8.51.
About Cyclo Therapeutics (OTCMKTS:CTDH)
Cyclo Therapeutics, Inc, a biotechnology company, develops cyclodextrin-based products for the treatment of diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. The company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.
Read More: How does new data get added to a blockchain?
Receive News & Ratings for Cyclo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.